PRospective Observation of Aortic reGuRgitation aftEr TAVI and progreSS Over Time: PROGRESS PVL Registry

NCT02987894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-04-09

No results posted yet for this study

Summary

The purpose of this post-market registry is to collect and monitor ongoing safety and performance clinical data of the ACURATE neo™ Aortic Bioprosthesis, and the ACURATE TF™ Transferral Delivery System, when used as per IFU.

Conditions

  • Aortic Stenosis

Interventions

DEVICE

ACURATE neo™ Aortic Bioprosthesis

TAVI, transcatheter aortic valve replacement. Transfemoral access.

Sponsors & Collaborators

  • Symetis SA

    lead INDUSTRY

Principal Investigators

  • Won-Keun Kim, Dr · Kerckhoff-Klinik Forschungsgesellschaft mbH

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Canada
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02987894 on ClinicalTrials.gov